skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines belzutifanQuestion & answer

belzutifan · Medicine question

What is the mean elimination half-life of belzutifan?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Belzutifan has a mean elimination half-life of approximately 14 hours, based on population pharmacokinetic analysis.

Sources for this answer

WELIREG 40 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 12Document updated 6 October 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about belzutifan

For which ages and disease stages is Welireg (belzutifan) indicated for pheochromocytoma or paraganglioma?How can belzutifan affect hormonal contraceptives?How long should breastfeeding be discontinued during and after belzutifan treatment?Is belzutifan recommended during pregnancy?Should Welireg (belzutifan) film-coated tablets be swallowed whole?What contraception precaution is recommended for men with pregnant partners during and after belzutifan treatment?

belzutifan

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the belzutifan guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX